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Objectives.We sought to evaluate changes in RR interval
variability during dipyridamole infusion and dipyridamole-
inducedmyocardialischemia.
Backgrwrd.MyocardiaIischemiaand the autonomicnervous
systemcan be mutuallyiuterdependent.Spectral analysisof RR
intervalvariabilityis a useful tool in assessingautonomictone.
Methods.Weused a time variant autoregressivespectral esti-
mationalgorithmthat couldextract spectralvariablesevenin the
presenceof nonstationarysignals.TWogroupswere considered:
group A (patients with ischemia,n = 15) with effortor mixed
angina, angiographieallyassessed coronary artery disease and
positiveexerciseand dipyridamoleechocardiographictest results,
and groupB (controlsubjects,n = 10)withnormal exerciseand
dipyridamoleechocardiographictest results. We investigatedthe
followingvariables:RRintervalmeanand variance,lowfrequency
(LF)and highfrequency(HF)powerin normalizedunits,LFratio
(LF/LF,a,., power), HF ratio (HF/HF..,,l power) and LF/HF
ratio. For each test epoch,wecalculatedfor groupAand groupB
the meanvalue&SEofall indexesconsidered.Differencesdue to
an effecteither ofgroup (ischemicvs. control)or of time (includ-
ing both drug and ischemia effects)were analyzed by using
analysisof variancefor repeatedmeasurements.
Resuk. Dipyridamoleinjectionwas characterizedby a reduc-
tion of all spectral componentsin negativetest, The LF ratio was
the onlyvariableable to discriminatepatientswithischemiafrom
controlsubjects(p < 0.05),whereasa time effectwas evidentfor
both mean RR interval and high frequencypowerin normalized
units (p c 0,05),TheLFratio decreasedin groupBfrom1 &0.00
(basal) to 0.31k 0.22(peak),and increasedin groupAfrom 1 &
0.00to 15.41& 6.59,respectively.Results of an unpaired t test
comparingthe peakvaluesofthe twogroupswerealsostatistically
significant(p < 0.01).
Conclusions.Our data showthat timevariant analysisofheart
rate variabilityevidencesan increase in the lowfrequeneyratio
that allowsdifferentiationof positivefrom negativetest results,
suggesting that the electrocardiogram may contain ischemia
informationunrelated to ST-Tvariations, evenif their enhance-









































1 LF 0.10 1.424e-004HF 0.26 7.936e-005VLF 0.00-0.03mLF 0.03-0,15HzHF 0.18-0.45Hr
0.5
Figure1. Plotof the (PSD)computedfroma
stationaryRR intervalseries from a norrnrdsubject.The power
spectraldensityis automaticallydecomposedin bell-shapedcurvesin
correspondencewiththemajorspectrrdcomponents;eachcomponent
is quantifiedby its centerfrequency(F) and by its area, that is, its
power(P), Powerspectraldensityunits are in s2/Hz,whereasthe
frequenciesare expressedin Hz.Thus,thepowerwillbe expressedin
= = 0.18to 0.45Hz;VLF= (1to 13.03HZ.
or a history of hypertension, diabetes, alcoholism.All
subsequent subjects meeting the inclusion criteria were en-
tered into the study.
Dipyridamole echocardiographic test. Two-dimensional
echocardiographicmonitoring was performed in combination
with dipyridamoleinfusion as follows:0.56mgikgbody weight
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respectively, as 1) the first appearance of any evidence of
Figure2.
a normal




every10newRR internals).Thevariousstepsofthe testare shownin
both panelson the time axis.The effectof dipyridamoleinfusionis










interval analysis. During the dipyridamole echocardi-









Spectral analysis: time variant algorithm. We used a time
variant spectral approach based on an autoregressive model
whose parameters are recursively updated according to the
current signal characteristics, whereas the importance of past
signal characteristics is progressivelyreduced by the action of
a~o~etting~actorOJ
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spectral characteristics up to one spectrum for
a
a o = a
a
a
Spectral variables. The series of the estimated spectra can
be looked at under the so-called compressed spectral array















a patientwithischemiaandpositivefindingson a dipyridamole(DIP)
echocardiographictest (see Fig. 2 for axis units). Dipyridamole
infusionis followedby a transitorydisappearanceof LF and HF
components.However,whenechocardiographicdyssynergyoccurs,the
LF componentreappearsin the compressedspectralarrayspectra.
Aminophyllineinfusioninducesa furtherincreasein LF power.D =









928 PETRUCCI ET AL.
HEART RATE VARIABILITYDURING DIPYRIDAMOLETEST
JACC Vol. 28, No. 4
October 1996:924–34




3 3 1 L
4 2 L












= = = =
F = H = + L =

























p = t ~
p = t VS. 9(J t
5 p = f f p =
~
t p = t f
p =
JACC Vol. 28, No. 4
October 1996:924-34
PETRUCC1ET AL. 929





































Data presented are mean value t SE. HF = high frequencycomponent;LF = low frequeneycomponent;n.u. =
Qualitative evaluation. Spectral changes during dipyrida-
mole echocardiography testing can be qualitatively evaluated
by visual inspection of compressed spectral array plots. The
pattern of changes is similar in all group B patients. Dipyrid-
amole infusionis alwaysfollowedby a progressivereduction in
both LF and HF components,with a shift of the residualpower
toward the VLF band. This typicalpattern is shownin Figure
2. The differencebetween the basal conditions (upper spectra)
and the dipyridamole infusion (middle spectra) is clearly
evident; the two spectral peaks (LF and HF peaks) that were
initiallypresent disappear after dipyridamoleinjection and are
restored onlyby aminophyllineadministration (lowerspectra).
In some patients, just before high dose infusion, there is a
slight reappearance of variability,which is suddenlydepressed
by the second dipyridamoleinjection. Aminophyllineadminis-
tration promptly restores the basal variabilitypattern.
In group A, too, low dose dipyridamoleinfusion induces a
reduction in both LF and HF power. However,when ischemia
occurs, an increase in LF power is invariably found in all
patients. The effectof ischemiais evidencedby the comparison
of Figure 2 (negative test response) and Figure 3 (positivetest
response); in synchrony with echocardiographic
3
a
Quantitative analysis. Table 2 and Figure 4 show, for
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Figure4, Meanvaluest SE of the analyzedheart rate variability
variablesduringrelevantperiodsof the dipyridarnolechocardio-
graphictest inpatientswithnegative(groupB)andpositive(groupA)
test findings.B = basal;HD = highdose;LD = lowdose;n.u. =





alwaysassociatedwith a further increasein LF power.
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Table4. Analysisof VarianceforRepeatedMeasurementson NormalandIschemicGroupData (FisherF values)
H
X






Figure 5. Representationof the LF ratio (LF/LFb,,.lpower)for
controlsubjectsduringdipyridamole(DIP)echocardiographictesting
(seetext for the computingprocedure).Time(in minutes)fromthe
beginningof the test and test phasesare depictedon the x axis,
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Spectral”patterns during dipyridamole testing. The main
effect of dipyridamole infusion on heart rate variability vari-
ables is a decrease in LF and
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Figure 6. Plot of the LF ratio
(LF/LF,~,~,power)for each pa-





group (dotted lines). Time (in
minutes)from the beginningof
the test and test phasesare de-
pictedon the x axis;the LF ratio






usuallyfollowedby a further in-
crease in LF power.Abbrevia-
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where H* is the complexconjugateof H. In the classicalbatch
least-squaremethod(50),the parametersof the modelcanbe esti-
matedfromthe databyminimizingthe followingfigureof meritJ:
J =
“=l,N
whereN is the numberof samples,and e(n) is the predictionerror
series,obtainedas the dtierencebetweenthe real andthe estimated
signalvalues.Theuniformwindowingin figureof meritJ makesthe
batchleast-squareapproachableto identifythesinglemodelthatgives
the bestwholedata fitting.In thisway,to obtaina consistentmodel
estimation,an unchangedsignal generationmechanismmust be
hypothesizedfortheentiredataset;thus,theprocesshasto remainin
a stationarycondition.
If this assumptionis not realistic,the signrdwilfnot remainin a








wherew (O<0< 1) is a real scalarcalleda forgettingfactor.The
exponentialweightgivesdecreasingimportanceto the past terms,
highlightingthe currentones and makingthe modelable to fit the
morerecentprocessproperties.
The choiceof o is usuallya cruciafpoint and mustbe madeby
consideringthebestcompromisebetweenfastconvergenceandnoise
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